NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/29/2025
Back to search
Official data from USPTO
MB MAINLINE BIOSCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
07/29/2025
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
11/17/2022
Registration date
07/29/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/29/2025
Last transaction
07/29/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/27/2024
First use in commerce
11/27/2024
Drawing code
5
Owner type
16
Owner location
Lingang, Shanghai, CN
Examiner
TOOLEY, DAVID E
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized "M" to the left of a stylized "B" to the left of the stylized wording "MAINLINE BIOSCIENCE".
Holders and representatives
Holders
Mainline Biosciences (Shanghai) Co., Ltd.
Representatives
Don D. Cha HDC INTELLECTUAL PROPERTY LAW, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention of cancer or tumor; Pharmaceutical preparations for the treatment and prevention of cancer or tumor; Pharmaceutical preparations for the treatment of cancer or tumor; Pharmaceutical preparations for cancer or tumor; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer or tumor
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/29/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/16/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/07/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
07/07/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/07/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
07/07/2025
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
07/07/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/26/2025
GNRT
NON-FINAL ACTION E-MAILED
02/26/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
02/26/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/12/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/12/2025
IUAF
USE AMENDMENT FILED
11/30/2024
EISU
TEAS STATEMENT OF USE RECEIVED
11/30/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/04/2024
PUBO
PUBLISHED FOR OPPOSITION
06/04/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/15/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/30/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
04/30/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/30/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
04/30/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/30/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/22/2024
ALIE
ASSIGNED TO LIE
04/22/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/01/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/01/2023
GNRT
NON-FINAL ACTION E-MAILED
09/01/2023
CNRT
NON-FINAL ACTION WRITTEN
09/01/2023
DOCK
ASSIGNED TO EXAMINER
08/30/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/09/2022
NWAP
NEW APPLICATION ENTERED
11/21/2022
Continuous trademark protection
Get notified about every new filing that threatens MB MAINLINE BIOSCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.